Artio Medical appoints Nathaniel Hagedorn to board of directors

Nathaniel Hagedorn Artio Medical has announced the appointment of entrepreneur and businessman Nathaniel Hagedorn to its board of directors. As the founder and CEO of NorthPoint Development, Hagedorn has raised over $6.5B in capital and brings nearly two decades of experience in accessing new markets and scaling new business opportunities. Hagedorn founded [...]

2020-05-01T12:25:25+00:00May 1st, 2020|Tags: , , |

Artio Medical Closes $8.8 million of additional dinancing

Artio Medical, a medical device company developing innovative products for the peripheral vascular and neurovascular markets, has closed an additional $8.8 million in Series A financing, bringing the total capital raised to date to more than $20 million. The additional funds will help Artio obtain 510(k) marketing clearance from the FDA to market the [...]

2020-04-01T16:06:12+00:00April 1st, 2020|Tags: , |

Metactive Medical changes name to “Artio Medical”

Metactive Medical has changed its name to Artio Medical, effective immediately. Artio Medical was founded in 2014 as a small research and development group focused on developing metal implants for vascular embolisation. The organisation has since grown to include a team, according to a press release, of exceptionally talented medical device professionals and expanded [...]

2020-02-17T13:13:26+00:00February 17th, 2020|Tags: , |